Skip to main content
Minnesota Department of Health logo
  • Main navigation

    • Home
    • Data, Statistics, and Legislation
    • Diseases and Conditions
    • Health Care Facilities, Providers, and Insurance
    • Healthy Communities, Environment, and Workplaces
    • Individual and Family Health
    • About Us
    • News and Announcements
    • Translated Materials

Main navigation mobile

  • Data, Statistics, and Legislation
  • Diseases and Conditions
  • Health Care Facilities, Providers, and Insurance
  • Healthy Communities, Environment, and Workplaces
  • Individual and Family Health
  • About Us
  • News and Announcements
  • Translated Materials
MDH Logo

Breadcrumb

  1. Home
  2. Data, Statistics and Legislation
  3. Prescription Drug Price Transparency
Topic Menu

Prescription Drug Price Transparency

  • Rx Transparency Home
  • Announcements
  • Data and Dashboards
  • Publications
  • For Reporting Entities

Related Sites

  • Health Economics Program
  • 340B Reporting
  • Accessible Prescription Drug Labels

Prescription Drug Price Transparency

  • Rx Transparency Home
  • Announcements
  • Data and Dashboards
  • Publications
  • For Reporting Entities

Related Sites

  • Health Economics Program
  • 340B Reporting
  • Accessible Prescription Drug Labels
Contact Info
Prescription Drug Price Transparency Program
651-201-4520
health.rx@state.mn.us

Contact Info

Prescription Drug Price Transparency Program
651-201-4520
health.rx@state.mn.us

Rx Data Reporting Portal Help

Here are several resources to support reporting entities when registering, reporting, and managing account access in the Rx Data Reporting Portal. 

Using the Rx Reporting Portal

All reporting types

  • Registration Quick-Start Guide (PDF)—all reporting types
  • Registration and Account Management Guide (PDF)—all reporting types

Prescription Drug Price Transparency Reporting: New Drug and Price Growth 

Manufacturers 

  • RxPT Online Reporting User Guide (PDF)
  • RxPT Frequently Asked Questions for Reporting Entities (PDF)
  • RxPT: Item Management Tutorial (YouTube)

Prescription Drug Price Transparency Reporting: Drugs of Substantial Public Interest 

Manufacturers, Wholesalers, Pharmacy Benefit Managers (PBMs), and Pharmacies

  • Frequently Asked Questions for RxPT Reporting Entities: Public Interest Reporting—June 2024 (PDF)
  • Frequently Asked Questions for RxPT Reporting Entities: Public Interest Reporting Supplemental Questions—September 2024 (PDF)
  • RxPT: Pharmacy Public Interest Reporting Tutorial (YouTube)
  • RxPT: Manufacturer Public Interest Reporting Tutorial (YouTube)
  • RxPT: Wholesaler Public Interest Reporting Tutorial (YouTube)
  • RxPT: Pharmacy Benefit Managers (PBMs) Public Interest Reporting Tutorial (YouTube)

340B Covered Entity Reporting

  • 340B Covered Entity Report: Frequently Asked Questions (PDF)
  • 340B Tutorial: Online Portal for 340B Reporting (YouTube)

More information on the Prescription Drug Price Transparency reporting initiative.

More information on the 340B Covered Entity Report initiative

Tags
  • rx transparency
Last Updated: 04/17/2025

Get email updates


Minnesota Department of Health logo

Privacy Policy
Equal Opportunity
Translated Materials
Feedback Form
About MDH
Minnesota.gov
  • Facebook
  • Twitter
  • Linked In
  • Instagram
  • Youtube
Minnesota Department of Health Minnesota Department of health print search share facebook instagram linkedin twitter youtube